INTRODUCTION
Recombineering is an in vivo method of genetic engineering used primarily in Escherichia coli that uses short 50 base homologies [1] [2] [3] [4] [5] . As recombineering is based on homologous recombination, it allows insertion, deletion or alteration of any sequence precisely and is not dependent on the location of restriction sites (Fig. 1) . Linear DNAs, either double-stranded (ds), usually in the form of PCR products 3, [6] [7] [8] , or single-stranded (ss) synthetic oligonucleotides 2, 9 are introduced by electroporation and provide the homologous substrates (i.e., targeting constructs) to create genetic changes. Recombineering is catalyzed by bacteriophage-encoded homologous recombination functions, such as the coliphage l Red system 3 and the RecET system from the Rac prophage 4, 10 .
This protocol will emphasize modification of bacterial artificial chromosomes (BACs) and multicopy plasmids but the procedures described are generally applicable to other replicons. A basic knowledge of molecular and microbiological techniques is required to execute the recombineering protocols described here. These basic techniques are described in detail by Ausubel et al. 11 . Recombineering protocols for manipulation of the bacterial and phage chromosomes are described elsewhere 12, 13 . Recombineering can also be used to modify episomal DNAs such as the low-copy plasmid derivatives of P1 and F that carry artificial chromosomes and are called PAC (P1 artificial chromosome) 14 and BAC 15, 16 , respectively. Although multicopy plasmids may be the ideal choice of vector when the insert size is relatively small (up to 50 kb), PACs, which accommodate inserts of 50-100 kb, and BACs, which allow inserts of 4100 kb, are used for cloning large genomic fragments. A BAC is the vector of choice for cloning and manipulating large DNA fragments. BACs may contain genomic segments that include all of the extragenic cis-regulatory elements (promoter, terminator and enhancers) of a gene of interest. BACs are therefore ideal for generating transgenic mice because the insert size may allow expression of the cloned gene under the control of its own regulatory elements, mimicking the endogenous expression pattern. In addition, because of the ease of obtaining desirable BAC clones coupled with simple DNA purification protocols, BACs are widely used in gene mapping and functional studies, analysis of regulatory elements and expression of a transgene under the control of a heterologous promoter 17 . They are also used for genetic analysis of mutations that have been identified in human diseases 18, 19 . BACs are modified by recombineering in E. coli, and these modified constructs can then be used to generate knockout and knock-in mouse models using embryonic stem cell technology 20, 21 .
The recombineering protocols described here use the bacteriophage l Red system that includes the phage recombination genes gam, bet and exo. The gam gene function, Gam, prevents an E. coli nuclease, RecBCD, from degrading linear DNA fragments 22, 23 , thus allowing preservation of transformed linear DNA in vivo. The bet gene product, Beta, is an ssDNA-binding protein that promotes annealing of two complementary DNA molecules [24] [25] [26] , and the exo gene product, Exo, has a 5¢ to 3¢ dsDNA exonuclease activity 27, 28 . Working together, these latter two proteins insert linear DNA at the desired target, creating genetic recombinants ( Fig. 1 ) 29, 30 . For dsDNA, Red Exo is thought to degrade from both 5¢-ends, exposing ssDNA that is bound by Red Beta. Use of the phage l Red system for in vivo genetic engineering was pioneered by Murphy et al. 6, 7 , who demonstrated dsDNA recombination with the Red functions expressed from the lac promoter, both on a multicopy plasmid and as an insertion on the E. coli chromosome. Murphy et al. 6, 7 used linear substrate DNA targeting homologies that were greater than 1 kb. Zhang et al. 4 demonstrated that the phage RecET system catalyzes recombination using targeting homologies of only 40-60 bp. This short-length requirement allowed the homologies to be incorporated into PCR primers, substantially advancing the technology. The l Red system was also shown to act on short homologies 3 . Ellis et al. 2 demonstrated that the l Beta protein promotes efficient in vivo recombination with ssDNA, provided as 70-mer ss-oligos. Models for how recombineering occurs 31 propose that the single-strand regions of the incoming linear DNA bound by the Beta protein are annealed to complementary single-strand gaps arising at the replication fork during DNA replication. Consistent with this model, an oligo able to anneal to the discontinuously replicated lagging strand gives a higher recombination frequency than its complementary 'leading strand' oligo 2 . When engineering DNA in vivo, it is important to provide a brief high-level pulse of the phage recombination proteins. Limited expression minimizes the toxic effects of the Gam protein 32 and minimizes undesirable genome rearrangements between repetitive DNA sequences. Although the phage recombination functions have been produced from multicopy plasmids under control of the IPTG-inducible lac promoter 6, 7 , the lac promoter has a high basal level and requires the lacIQ repressor gene in cis for tight regulation. A better choice is the arabinose-inducible pBAD promoter 33, 34 . In Ara + strains, the pBAD promoter can be tightly repressed by addition of glucose to the growth medium; however, in ara mutants, glucose-mediated repression is less effective, even with the araC gene on the plasmid 35 . When the pBAD plasmids are used for recombineering 34 , glucose is not added during cell growth and arabinose is usually added at least a generation before the cells are made competent for electroporation. This procedure, although convenient for induction, does not yield the tightest possible repression 35 . In contrast, expression from the l prophage system is based on the endogenous l regulatory system, which is the natural method for expression of these recombination functions. The most recent studies on l (see refs. 36,37) show that its repression system is uniquely strong: the l repressor binds cooperatively at the three operator sites present at both the pL and pR promoters, and these two sets of repressor-bound operators interact with each other by protein-protein-mediated looping between pL and pR to generate a handcuff of 12 repressor proteins. To ensure this same tight repression during recombineering, both sets of operators are present on all of the prophage constructs, whether they are in the bacterial chromosome or on low-copy plasmids, and a temperature-sensitive repressor is expressed from the cI857 gene. At low temperatures (30-34 1C) , the repressor is active and the recombination genes are not expressed. When the temperature of the bacterial culture is shifted to 42 1C for 15 min, the repressor is rapidly inactivated, and the recombination genes are expressed at high levels from the powerful lpL promoter. Repressor is renatured and tight repression is restored by lowering the temperature after 15 min. The short induction time minimizes adventitious recombination and cellular stress 32, 38 . An advantage of the natural phage system is that the l repressor is autoregulated and, thus, better controlled than when recombination genes on multicopy plasmids are expressed from heterologous promoters, which are often leaky, causing unwanted expression and side effects. Red recombination does not require the E. coli RecA function 3 , and when recombineering is performed in a strain with a recA mutation, all extraneous homologous recombination is prevented.
Owing to its high efficiency and short homology requirements, recombineering can be used for a wide range of applications (Fig. 2) . Recombineering can be used to insert selectable or nonselectable markers in plasmids, bacterial chromosomal DNA or BACs. It can be used to generate gene-targeting constructs to be used for making knockout or knock-in alleles in embryonic stem cells. This technology is also suitable for generating transgenic reporter constructs using BACs to express lacZ, fusion tags (e.g., GFP, tandem affinity, FLAG, HIS and so on), site-specific recombinases (e.g., Cre, Flp), selectable markers (e.g., neomycin resistance gene) or any cDNA under the control of a tissue-specific promoter or to make fusion proteins. It can also be used to generate subtle alterations in BACs or bacterial chromosomal DNA without the use of any selectable marker or site-specific recombination system.
In spite of being a very tractable and versatile technology, recombineering has limitations. For example, as very short regions of homology are sufficient for the recombination, manipulating regions containing repetitive sequences can be problematic. As most recombineering-based methods use PCR-amplified products as substrate DNA, the recombinant products may occasionally acquire mutations. However, confirming the integrity of the recombinant target DNA by sequencing helps to discard such products. Another limitation of recombineering is that the sequence of the target region must be known. However, because the entire genome of many organisms has been sequenced, this is not a limitation for most commonly used organisms.
Experimental design
Each recombineering experiment involves the following six steps, which are illustrated in the general flowchart (Fig. 2) . Substrate DNA design and generation. Depending upon the application, different DNA substrates are required (Fig. 2) . The creation of appropriate double-stranded and single-strand linear targeting substrates for specific applications is described below and their construction is detailed in Step 3 of PROCEDURE.
Double-stranded DNA recombination. Linear dsDNA substrates for recombineering consist of a region to be inserted flanked by two homology arms. The inserted region may be either a selectable p u o r G g n i h s i l b u P e r u t a Nmarker or a nonselectable DNA that is used to replace a counter-selectable marker.
Recombineering can be used to insert a selectable marker (drug resistance gene or a prototrophic marker) into the bacterial chromosome or any episomal DNA. This is done by using linear DNA containing the desired selectable marker flanked by 50 bases of homology to the target site ( Figs. 1 and 3) . Such substrates can be made with the PCR by amplifying the selectable markers using a pair of chimeric primers, each about 70 bases in length. Each primer will have 50 bases at the 5¢-end corresponding to the region to be targeted to provide homology and B20 bases at the 3¢-end to prime amplification of the selectable marker as shown in Figure 3 . Although flanking 50 base homologies are more than sufficient for recombination, longer homologies of 150-200 bases have been used to further improve the targeting efficiency; however, this substantially increases the time and effort required 6, 21 . To use longer homologies, each homology arm is amplified independently by PCR and directionally cloned into a plasmid so as to flank the selectable marker already present in that plasmid. High-fidelity Taq DNA polymerase with proofreading ability (such as Invitrogen High Fidelity Platinum Taq or Roche Expand High Fidelity) is used for generating dsDNA PCR products for recombineering substrates; for confirming constructs, standard Taq polymerase can be used. Try not to use supercoiled DNA as template for PCR amplification, as residual intact plasmid will give a high background of transformants, making it difficult to identify actual recombinants. The TKC strain (Table 1) contains the three genes for antibiotic resistance to tetracycline, kanamycin and chloramphenicol, as well as their regulatory elements. This strain can be used to amplify any of these markers with the colony PCR technique using the primer pairs specified in Table 2 (see option A in Step 3 of PROCEDURE, Fig. 3a ). Plasmid templates with selectable markers flanked by loxP and FRT sites are available through the NCI recombineering website (http://recombineering.ncifcrf.gov/; see option B in Step 3 of PROCEDURE, Fig. 3a ). Drug cassettes with dual promoters that allow the use of the same selectable marker (e.g., neomycin, hygromycin and blasticidin) in both bacterial and mammalian cells are also available. A nonselectable DNA fragment (e.g., a reporter gene, such as lacZ, a transgene, such as cre, flp or GFP, or a HIS-tag) can also be efficiently inserted into a genomic region using recombineering. There are two approaches to achieve this. The first approach is a two-step selection/counter-selection method that allows insertion of the desired DNA without leaving other undesirable modifications, in a 'seamless' event (Fig. 4a) . Generally, a counter-selectable cassette is first inserted at the site to be changed; this cassette is then 43 . In many situations, such as when using galK, the same gene can be selected both for and against (Fig. 4a) .
The galK counter-selection has been optimized for use with BACs and uses strains that have been deleted for the galK gene at its normal chromosome location; such strains include SW102, SW105 and SW106. A detailed protocol for the galK counter-selection has been published 40 . For convenience, the strains and plasmids used in the galK selection are listed in Tables 1 and 3 . In the second approach, a selectable marker is linked with a nonselectable DNA fragment and the two are inserted together (Fig. 4b) . If subsequent removal of the selectable marker is desired, it can be flanked with loxP or FRT sites, thus allowing excision by expression of the Cre or Flp proteins 44 . Template drug cassettes with flanking loxP and FRT sites that can be used for PCR amplification are also available from the National Cancer Institute recombineering website. As a single loxP or FRT site remains after the genetic manipulation, we refer to this as the 'scarred' method ( Fig. 4b) .
Recombineering is now routinely used as a subcloning technique. Whereas classical methods of subcloning using restriction enzymes and DNA ligase allow manipulation of small DNA fragments, recombineering allows precise retrieval of even a large DNA segment from a genomic fragment in a BAC or from the bacterial chromosome 21, 44 . Recombineering allows the junctions of the subcloned fragment to be exactly determined on the basis of need rather than on chance location of restriction sites. For rapid subcloning by recombineering, the small retrieval vectors are generated with PCR using a pair of primers, each with 50 base homologies at the 5¢-ends corresponding to the region to be retrieved and B20 bases of plasmid sequence for PCR amplification ( Step 1
Step 1
Step 2
Step 2 (a) 'Seamless' method to insert nonselectable DNA fragment makes use of selectable markers that can be used for positive as well as negative selection (e.g., galK). In this two-step method, first the selectable galK marker is targeted to the site (Gene X) where the nonselectable DNA fragment (Gene Y) is to be inserted. In the second step, a targeting construct containing the nonselectable DNA fragment flanked by the same 50 bp of homology to the target site is electroporated into Gal + bacterial cells containing the recombinant DNA from Step 1. Clones in which the Gene Y DNA fragment is correctly targeted are counter-selected for loss of the galK gene. (b) The scarred method: this method targets both the selected (Neo) and nonselected (Gene Y) DNAs jointly. In Step 1, the nonselectable DNA fragment (Gene Y) is introduced along with a selectable marker, Neo, which is flanked by loxP or FRT sites. Recombinants are selected for the presence of Neo. In Step 2, Neo is deleted by site-specific recombinase-mediated recombination (Cre for loxP sites and Flp for FRT sites). Unlike the 'seamless' method, a single loxP or FRT site is retained after recombination. be cloned to improve retrieval efficiency if necessary 21 . A plasmid template must be used when amplifying the linear retrieval vector backbone, usually consisting of an origin of DNA replication and a selectable marker (option C in Step 3 of PROCEDURE, Fig. 5a ). When the linear retrieval vector contains a selectable marker, however, a potential side reaction of end-joining can occur, generating a circular plasmid carrying only the selectable marker 5 . This is avoided by using a retrieval vector that contains only the origin of replication; in this approach, the selectable marker is first inserted adjacent to the target DNA to be retrieved. See Datta et al. 45 for details. The linear targeting construct recombines with the target DNA and retrieves the desired fragment by gap repair. This results in the generation of a circular plasmid (Fig. 5b) . When gap repair is used for retrieving DNA, it is not necessary to know the DNA sequence of the entire piece to be retrieved, only that of the flanking region used as targeting homology. When the length of the fragment to be retrieved is less than 15 kb, a high-copy plasmid (e.g., pBluescript) can be used, but a lower-copy plasmid (e.g., pBR322) should be used for larger fragments 44 . In a variation of this method known as 'in vivo cloning' 5 , a linear DNA to be incorporated onto the plasmid, often generated by PCR, is coelectroporated with the linear plasmid. DNA can also be transferred by retrieval from one BAC to another as has been described 46, 47 . Single-strand DNA recombination. Recombineering can also be performed using synthetic oligonucleotides (see Step 2 in PROCEDURE) or short denatured PCR products 2, 8, 9, 48 . These oligos (ss-oligos) or ssDNAs can be used to create single base changes, insert or substitute short DNA sequences and generate deletions. Under optimal conditions, creation of small changes with recombineering using ssDNA is highly efficient and often completely eliminates the requirement for any selection. Two different variables contribute to creation of these optimal conditions. One variable is use of a 'lagging-strand' oligo, i.e., a single strand corresponding in sequence to the DNA chain that is replicated discontinuously 2, 9 . Which of the two complementary oligos corresponds to the lagging-strand oligo will depend on the direction of DNA replication through the region of the chromosome or episome to be modified, and often it is easier to just try both strands; one should recombine with a 20-to 30-fold higher efficiency than the other. The other important variable includes avoidance of the E. coli methyl-directed mismatch repair (MMR) system: preventing MMR increases the effective recombination frequency about 100-fold 9, 49 . As strains mutant for the MMR system acquire adventitious mutations, procedures that avoid the use of MMR mutants have been devised. The simplest of these tricks is to use an oligo that creates a C-C mispair when annealed to the target DNA, as the MMR system does not recognize and remove this particular mismatch. This method has limited utility, however, and other more generally useful two-step procedures are illustrated below.
A 'hit and fix' two-step recombineering approach 48 , in combination with screening by colony hybridization, can be used to generate and find subtle changes in BAC DNA (Fig. 6 ). This approach is particularly useful for modifying DNA regions with repetitive motifs, which can be difficult to screen by PCR. This method uses short (B180 bp) dsDNA fragments generated by PCR that can be denatured to provide ss-oligonucleotide substrates for recombineering. In the first 'hit' step, a stretch of 20 nucleotides is changed, including the nucleotide(s) to be mutated in the final construct. The altered sequence is designed to contain recognition sites for a restriction enzyme. In the second 'fix' step, the bases that were modified in the first step are restored to the original sequence, with the exception of the desired mutation(s). As a run of nucleotides is changed at each step, the recombinant BACs can be detected by colony hybridization using a primer specific for the altered bases. Colony hybridization allows thousands of individual colonies to be screened at once. The presence or absence of the restriction site provides an additional tool to rapidly confirm both the 'hit' and 'fix' steps. The central 20-bp region can be the same for all 'hit' PCR products, allowing one 20 base universal probe to be used to identify the inserts at the 'hit' step. See Box 1 for generation of 'hit and fix' substrates and Step 19D of PROCEDURE for identifying recombinants by the 'hit and fix' method.
Oligonucleotides can also be used to precisely delete unwanted regions of DNA by designing a 70-mer lagging strand oligo that spans the portion to be deleted, with 35 bases of homology at either side. The efficiency of deleting large segments is lower than that of engineering small single-base changes, and a selection or screen will be needed to identify recombinants 2, 8, 9, 50 . As an example, a counter-selection can be used in combination with an oligo to generate deletions when needed. Alternatively, colony hybridization, using a 20-base probe spanning the deletion with ten bases on each side, can be used to identify recombinants. Modifying multicopy plasmids. Recombineering is useful for making point mutations and small changes on plasmids 3, 5, 50 . For inserting or deleting larger pieces of DNA without a selection, classical cloning methods may sometimes be easier, but the precision of making junctions is usually lost. The plasmid to be engineered can be introduced into the Red-expressing cells by co-electroporation with the linear DNA after the recombination functions are induced; alternatively, it may be resident in the recombineering host. Coelectroporation of the plasmid with the modifying DNA, as described in Step 16 of PROCE-DURE, is often preferable, as it helps control the number of plasmids present at the time of recombineering and may minimize opportunities for plasmid multimer formation. Recombineering will occur only in cells receiving the plasmid, so when introducing the plasmid by coelectroporation with the linear substrate, enough plasmid molecules must be added to obtain a high transformation frequency, but not so high as to introduce large numbers of plasmid molecules per cell. This is generally about 10 ng of plasmid DNA per electroporation, but the appropriate amount of plasmid DNA to add may have to be determined empirically by generation of a transformation efficiency curve, as the transformation efficiency of plasmids may differ (see Box 2) . Ideally, each cell should receive about one plasmid molecule. If the plasmid is very large and has a low copy number, coelectroporation may not be practical; in this case, a resident plasmid should be used for modification.
The intracellular copy number of commonly used plasmids such as pUC derivatives may exceed 500 copies per cell 51 . Such a high copy number means that most copies will not be altered during a recombineering reaction, and cells that contain recombinant plasmid molecules will also contain many unmodified parental molecules. To create pure clonal populations of the recombinant, it is necessary to separate the recombinant class from the unmodified class; this is done by isolating the plasmid DNA after recombineering and retransforming it at a low concentration of less than one molecule per cell. If plasmid DNA has been deleted during the recombineering, often the plasmid mixture can be digested with a restriction enzyme that cuts only the parental plasmid species but not the desired recombinant, thus enriching for the recombinant class.
When making changes on plasmids, it is important to begin the procedure with a pure monomer plasmid species. By the same token, it is also important to use a host defective in RecA-mediated homologous recombination to prevent plasmid multimer formation by host recombination pathways. However, it has been observed 3,50 that when plasmids are modified with recombineering, Step 1, a 180-mer ss oligonucleotide is used to replace 20 nucleotides (gray box) around the target site with 20 heterologous nucleotides (black box). Recombinants can be identified by colony hybridization using an end-labeled 35-mer oligonuclotide that can specifically anneal only to the recombinant DNA. A primer set specific for the heterologous 'hit' sequence (P3 and P2) can be used to confirm the presence of recombinant clones by PCR. A second primer set (P1 and P2) can be used as a control to amplify only the nonrecombinant DNA. Generation of a correct recombinant clone can be confirmed by digesting with BamHI, EcoRV or XhoI the PCR product (approximately 300-500 bp) of primers P2 and P4. In Step 2, the 20 nucleotides are restored to the original sequence, except for the desired mutation. Such clones can be identified by colony hybridization using a 35-mer oligonucleotide as probe and further confirmed by PCR amplification using primers P1 and P2, by testing for loss of the restriction sites inserted in Step 1, by digesting the PCR product of primers P2 and P4 and by sequencing. some larger multimeric circles of these plasmids arise. As these multimers form during and are dependent upon the recombineering reaction, they cannot be totally eliminated. There is anecdotal evidence that other replicons, including BACs, may also form larger-order multimers during recombineering. Ways to deal with these multimers are suggested in the Troubleshooting section.
Provision of the k Red recombination genes. There are several ways to provide the prophage system that will express the phage recombination proteins in the bacterial cells where recombineering is performed (Fig. 6 ). All variations allow highly efficient recombination, and the choice of which to use will depend on the target DNA (see Fig. 2 ). When high-or low-copy plasmids have to be manipulated, bacterial strains containing the prophage recombination system on the chromosome (e.g., DY380 and its derivatives, such as SW102) should be used. When the bacterial chromosome or BAC DNA is modified, mobile recombineering systems, such as the pSIM vectors, mini-l or the replication-defective l phage (lTetR), can be introduced into the bacterial cells to be engineered (Fig. 7a-d) . BAC DNA can also be transformed into bacterial strains containing the repressed recombination system. In all cases, it is advisable to check the integrity of the BAC DNA by restriction analysis before proceeding with the recombineering procedure. The individual options are discussed in more detail below.
Bacterial strains with defective prophage; DY380 and derivatives. A number of bacterial strains have been generated that harbor a defective l prophage that is stably situated in the bacterial chromosome (see Step 4A of PROCEDURE, Fig. 7b and Table 1 ). Such host strains are ideal for manipulation of plasmid DNA, which can be introduced into these bacterial strains. Another major advantage of using the strains containing the integrated l prophage is that a drug selection need not be applied to maintain the recombineering system. Strains routinely used for BACs include DY380 44 , SW102 and their derivatives 40 . To use these strains, the BAC or plasmid to be modified must be introduced into the recombineering strain by transformation (see Box 3). A mini-prep method described below repressor. This repressor is temperature sensitive in that it is active and represses the promoter at 30-32 1C but is inactive at 42 1C allowing for transcription. The N protein functions as a transcription anti-terminator and prevents RNA polymerase termination of pL transcripts at terminators tL1, tL2 and tL3. The red genes exo, bet and gam encoding the homologous recombination functions are also in the pL operon. The kil gene is adjacent to gam and, when expressed for over 1 h, kills the bacterial cell 32 . The replication genes O and P are in the pR operon. Cro functions as a partial repressor of the pL and pR operons when CI is inactive at 42 1C. The lysis and structural genes, SRA-J, are shown located beyond their regulator Q. The l TetR phage used for recombineering is identical to the above complete prophage with the exception of four changes. The replication gene P has an amber mutation, the cro gene also has an amber mutation, and the tetA gene encoding tetracycline resistance replaces rex. (b) The defective prophages in DY380, SW102 and the HME strains have the lytic pR operon deleted from cro through the bioA genes as shown in brackets. The right att site is also deleted, preventing any excision of this prophage. In DY380 and SW102, cro through bioA is replaced by the tetracycline resistance cassette, tetRA. (c) The mini-l phage DNA is shown with the lytic genes cro through J deleted. In different constructs of the mini l, the cro-J region is replaced with various drug-resistant cassettes. Mini-l has both att sites plus int and xis, which allows for its integration and excision. (d) The l segment on the pSIM plasmids is shown. The plasmid backbone is not shown. The genes from cro to att are removed as well as genes beyond tL3, including int and xis. The red genes are connected directly to pL by a deletion that removes kil through N. The drug-resistant marker characteristic of each SIM plasmid replaces the rex gene adjacent to cI857. The basic features are conserved in all of these Red expression constructs. Red is left under the native phage-controlling elements for optimal expression and regulation. The pL promoter drives gene expression and is controlled by the temperature-sensitive but renaturable l CI857 repressor. In all, the cro gene is inactive to maximize pL expression, and the replication genes are absent or inactive to prevent lethal effects on the cell.
BOX 2 | DETERMINATION OF PLASMID DNA TRANSFORMATION EFFICIENCY TIMING 1 D
1. Make electrocompetent cells as described in the protocol (PROCEDURE Steps 9-15), adding a different amount of DNA to each of several electroporations (suggested range is 0.1, 1, 10 and 100 ng). 2. Outgrow the electroporation mixes for 2 h and plate tenfold serial dilutions on Petri plates, selecting for the plasmid drug resistance. Use a range of dilutions to obtain countable number of colonies for each transformation. 3. The next day, count colonies and generate a semilog graph of the number of transformants (ordinate) versus the amount of DNA added (abscissa). 4. From the graph, determine the minimum amount of DNA necessary to achieve maximal transformation efficiency (i.e., without adding excess DNA), and use this amount of DNA for each recombineering reaction. ? TROUBLESHOOTING (see Box 4) works well for rapid extraction of BAC DNA and produces DNA that is suitable for restriction digestion, PCR analysis and sequencing 52 . For targeting both BACs and any multicopy plasmids, it is important to use recA mutant strains such as these.
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Mobile recombineering systems; mini-l and pSIM plasmids. There are mobile recombineering systems available that can be introduced into any bacterial strain to allow manipulation of the BAC or chromosomal DNA. Such mobile elements include 'mini-l' 53 and the plasmids collectively called the pSIM vectors 45 (see Steps 4B and 4C of PROCEDURE, respectively). Both mini-l and the pSIM plasmids provide the same endogenous phage-controlling elements and Red recombination functions present in the above-mentioned defective prophage strains (see Fig. 7c,d) ; however, these must be introduced into the BAC-containing strain. Mini-l consists of a defective nonreplicating, circular phage DNA, which, once introduced into the strain, integrates into the bacterial chromosome using site-specific recombination 53 . The integrants are selected by the presence of the antibiotic resistance gene carried by the mini-l. Once integrated, mini-l is stable, replicates as part of the host chromosome and does not require drug selection for maintenance. The mini-l includes the pL operon from which are expressed the int and the xis genes that catalyze the site-specific integration/ excision events, as well as the exo, bet and gam recombination genes for recombineering (Fig. 7c) . In addition to being easily introduced into any bacterial cell, the mini-l can be readily excised to cure the cells of the phage DNA. The excised mini-l DNA circle can also be purified from the induced bacterial cells using a standard plasmid purification protocol. The pSIM vectors 45 consist of the elements of the prophage necessary for recombineering (see Fig. 7d ) carried on a number of different plasmid origins. Especially useful is a pSC101 plasmid derivative with temperaturesensitive DNA replication; this plasmid has a low copy number and the ts replicon allows loss of the plasmid after recombineering is completed. These plasmids are available with a variety of selectable antibiotic resistance markers ( Table 3) . Unlike the prophage and the mini-l, they require drug selection for stable maintenance.
l phage carrying tetracycline resistance gene; lTetR. A further means of expressing the Red system is from a l phage carrying a tetracycline resistance gene 20 (see Step 4D of PROCEDURE). This phage system combines the advantages of stability and mobility. The genotype of this phage is l cI857 ind1 rexABo4 tetAR cro TYR26am P GLN59am , and it is referred to here as lTetR (see Fig. 7a ). The lTetR is easy to prepare as a high titer phage lysate; using this lysate, lysogens are readily created by infection of the desired host and TetR selection. The efficiency of lysogeny is greater than that of plasmid transformation, and once introduced into the BAC-containing strain, the prophage is very stable and drug selection is no longer required. 
BOX 4 | SMALL-SCALE MINIPREP FOR BAC DNA PREPARATION TIMING 1.5 H
Induction of the k recombination genes. The Red system is induced by incubating the mid-log bacterial culture in a 42 1C water bath shaking at 200 r.p.m. for 15 min as detailed in Steps 6-8 of PROCEDURE. It is important to note that air shakers are not satisfactory for this purpose because the heat transfer is less efficient with an air shaker. Immediately after the heat pulse, the cells should be placed in an ice-water slurry for quick chilling. Failure to rapidly chill the cells may result in premature decay of the recombination activity. Once the cells are induced for the Red functions, it is best to complete the procedure promptly.
Preparation of electrocomptent cells and electroporation of the linear targeting substrate DNA (see Steps 9-18 of PROCE-DURE). The chilled cells are gently washed twice with cold sterile water to remove salts that will cause problems during electroporation. The washed cells are suspended in a small volume of water and mixed with the linear DNA substrate, then aliquoted into chilled electroporation cuvettes. Luria broth (LB) is added immediately after electroporation to maximize recovery of viable cells.
Outgrowth following electroporation. The cells are fragile after electroporation and require a minimal 30-min recovery period in LB before plating. An outgrowth period may also be needed to allow expression of cloned genes, such as those encoding antibiotic resistance. The details of the outgrowth procedure will vary according to the type of recombineering reaction performed and how the recombinants will be identified. The various types of outgrowth are described in Step 19A-D of PROCEDURE.
Identification and confirmation of the recombinant clones. Drug-resistant recombinants are first selected using the appropriate antibiotic resistance and then analyzed with PCR to verify that the insertion has gone to the proper location. In certain cases, such as for multicopy plasmids, restriction analysis may be used to confirm the recombinant clones. Southern blots and sequencing may be used to analyze BAC or genomic recombinants. When a point mutation or other subtle change is made, DNA sequencing must be used to confirm correctness of recombinants. Recombinant identification is described in Steps 19A-D of PROCEDURE.
MATERIALS

REAGENTS
. One of the following is required to express the Red functions (see Experimental design for further details):
. Bacterial strain containing defective l prophage (see Table 1 ) . Mini-l DNA (see Table 3 ) . pSIM plasmid (see Table 3 ) . lTetR phage with titer of at least 10 9 plaque-forming units ml À1 . Ampicillin (A0166, Sigma) . Kanamycin (K0254, Sigma) . Chloramphenicol (C7795, Sigma) . Tetracycline (T7660, Sigma) . Hygromycin . Purified PCR product with 50 bp of homology to the target, B100 ng ml À1 . 70-mer ss-oligo (salt-free but otherwise unpurified) with desired changes(s) at center and with B35 bases flanking homology, 0.5 pmol ml À1 (Integrated DNA Technologies)
. Plasmid backbone with flanking homology to DNA to be retrieved, design) and order or synthesize them as salt-free and otherwise unpurified. m CRITICAL STEP Be sure to include the 50 bases of flanking homology to the 5¢-ends of your primers (see Experimental design). m CRITICAL STEP ss-oligos can be directly used as substrates for recombineering after appropriate dilution.
3|
To generate dsDNA substrates for recombineering by PCR, different templates can be used as follows: option A for bacterial DNA (Fig. 3a) , option B for plasmid DNA (Fig. 3a) and option C for plasmid origin amplification (Fig. 5a ).
(A) PCR-amplification of dsDNA substrate for recombineering from bacterial DNA TIMING 3-4 h (i) Antibiotic resistance genes containing tetracycline, kanamycin and chloramphenicol cassettes can be amplified from the TKC strain using 'colony PCR' and primer pairs listed in Table 2 . To perform colony PCR, prepare a PCR without allowing any volume for the template DNA; for a typical 50-ml PCR, using the high-fidelity Platinum Taq kit from Invitrogen, mix the following in a 0.2-ml PCR tube using sterile technique (for multiple PCRs, prepare a master mix and dispense aliquots as appropriate):
5 ml of 10Â PCR buffer 2 ml of 50 mM MgSO 4 1 ml of 10 mM dNTP mixture 1 ml of each primer (25 pmol ml À1 in H 2 O) 0.5 ml of platinum Taq high fidelity 39.5 ml of sterile distilled H 2 O (ii) Lightly touch a fresh colony of the E. coli strain with a sterile inoculating loop and mix cells into the PCR. (iii) Use the following PCR program suitable for amplifying any of the drug cassettes referred to in Hold at 4 1C (iv) Visualize the PCR on an agarose gel as described elsewhere 11 . (v) Remove salt and clean up the PCR product by ethanol precipitation as described elsewhere 11 or by using a commercially available kit and following the manufacturer's instructions. (vi) Suspend the product in small volume of H 2 O so as to have a concentration of B100 ng ml À1 .
(B) PCR-amplification of dsDNA substrate for recombineering from plasmid DNA TIMING 3-4 h (i) Plasmid templates must be linearized before PCR amplification. Digest plasmid DNA with a restriction enzyme at sites present in the vector sequence but absent in the sequence to be amplified 11 . (ii) Run an aliquot of the DNA on an agarose gel to verify complete digestion 11 . m CRITICAL STEP Be aware that super-coiled plasmid migrates at B70% of the size of a full-length linear species. (iii) If necessary, cut the band containing the linearized DNA from the gel and extract the DNA 11 . (iv) Resuspend the linear DNA in 20-30 ml TE (pH 8.0), check the concentration using a spectrophotometer (read absorbance at 260 nm) and dilute to 0.5-1.0 ng ml À1 . A purified fragment containing just the drug cassette can be stored and reused as template. (v) Amplify the drug cassette with a pair of chimeric primers, using PCR conditions based on information in Table 2 and a Taq DNA Polymerase with proofreading ability. (vi) Examine the PCR product by agarose gel electrophoresis 11 .
(vii) Gel-purify the desired band 11 to eliminate contamination of supercoiled plasmid. (viii) If linear plasmid DNA was used as template and the product was not gel-purified, digest the PCR with 3-5 U of the modification-dependent restriction enzyme DpnI per mg DNA (at 37 1C for 2 h), which will cut the plasmid DNA but not the unmodified PCR product. DpnI digestion may not totally eliminate plasmid background, however. m CRITICAL STEP Do not expose the PCR product to direct UV light, which may damage it and result in abnormal recombination frequencies. (ix) Clean up the PCR product as described in Step 3A(v). m CRITICAL STEP Do not use supercoiled DNA as template for PCR amplification. To avoid having to gel-purify the DNA or treat with DpnI, use the TKC strain as a template when possible. (C) Generation of dsDNA substrate for recombineering by PCR amplification of plasmid origin for gene retrieval TIMING 3-4 h (i) Digest the plasmid with one or more restriction enzyme(s) that do not cut within the region to be amplified.
(ii) Amplify the origin and selectable marker from the linear plasmid by PCR using the primers generated in Step 2 (reaction conditions will need to be established empirically). Use the least amount of linear plasmid possible for the PCR template, to minimize residual uncut plasmid. (iii) Digest the completed PCR with DpnI to further remove the template plasmid as in Step 3B(viii). (iv) Purify the PCR product to remove salt before proceeding (as in Step 3A(v) ). The amplified product will be a linear plasmid with flanking homology to either side of the region to be rescued from the chromosome. It is possible to avoid the potential side reaction of plasmid end-joining by using an alternative approach: amplify a retrieval vector containing only the origin of replication, after first inserting a selectable marker different than the one on the starting plasmid next to the target DNA to be retrieved 45 . See Box 1 for generation of 'hit' and 'fix' PCR products. ? TROUBLESHOOTING Provision of the k Red recombination genes 4| Provide the l recombination genes from the defective prophage present in DY380 and its derivatives (option A), the mini-l (option B), a pSIM plasmid (option C) or the replication-defective lTet phage (option D). m CRITICAL STEP It is critical to realize that in all cases, the Red genes are under control of a temperature-sensitive repressor, and strains containing them should always be propagated at a low temperature ( (iii) Chill the culture on ice for 15 min and extract the mini-l DNA using a standard plasmid midi-prep purification kit (e.g., Qiagen) as described previously 53 . (iv) Introduce the mini-l into the desired E. coli strain that will be used for recombineering by mixing 1 ml of mini-l DNA (25-35 ng) with 25 ml of electrocompetent bacterial cells and introduce the DNA by electroporation. Also do a control electroporation of cells alone without added DNA. (v) Grow the transformed cells at 32 1C for 1 hour in LB medium and plate dilutions on an LB agar plate containing the appropriate antibiotic to select the strain with mini-l (see Table 4 , use antibiotic concentration indicated for single-copy plasmids). Incubate overnight at 32 1C. (vi) Pick isolated colonies for recombineering and test for the presence of the prophage by confirming that the strain is temperature sensitive for colony formation on antibiotic plates at 42 1C.
(C) Provision of the k Red recombination genes from pSIM plasmids TIMING 1 d (i) Introduce the pSIM plasmid DNA into the bacterial strain where recombineering will be performed by selecting for the appropriate antibiotic resistance of the plasmid and plating the cells at 30-32 1C (see Table 4 , use antibiotic concentration indicated for multicopy plasmids). (ii) Purify a single colony 30-32 1C and grow an overnight culture from it with the appropriate antibiotic using methods described elsewhere 11 .
(D) Provision of the k Red recombination genes from replication-defective kTet phage TIMING 1 d
(i) Grow a 1-ml culture of the appropriate bacterial strain that will be used for recombineering overnight in LB, adding chloramphenicol (10 mg ml À1 ) if a BAC is present. 5| Inoculate the bacterial strain containing the Red functions from a single colony into 3-5 ml of LB medium. Incubate the culture at 32 1C overnight with aeration. m CRITICAL STEP Maintain antibiotic selection for the BAC (chloramphenicol 10 mg ml À1 ), and if a pSIM plasmid is used, also include the antibiotic for the pSIM (see Table 4 , use antibiotic concentration indicated for multicopy plasmids). ' PAUSE POINT Once the recombineering strains are created, they can be frozen and stored indefinitely for future use at À70 1C as a glycerol stock prepared by mixing 1 ml of a freshly grown overnight culture with 1 ml of 50% glycerol (dilute glycerol in water (vol/vol) and autoclave).
Induction of the k recombination genes TIMING 3 h 6| Add 0.5 ml of the overnight culture to 35 ml of LB medium in a 250-ml baffled Erlenmeyer flask. Supplement with appropriate antibiotic to maintain plasmids, if needed. Use antibiotic concentration indicated in Table 4 . m CRITICAL STEP Dilute the overnight culture by at least 70-fold. 
7|
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In labeled microcentrifuge tubes on ice, mix 1 ml of DNA from Step 3 (B100 ng of salt-free PCR fragment or 0.5 pmol (B100 ng) ss-oligo) with 50 ml of electrocompetent induced or uninduced cells from Step 14. When modifying a multicopy plasmid introduced by coelectroporation, also add 1 ml of the multicopy plasmid DNA (B20 ng ml À1 ) at this point. Include the following controls:
Induced cells without DNA. If colonies are present on this control plate, either the selection is not working properly or the cells have a high reversion frequency for the property selected. Uninduced cells plus DNA. This is a control to estimate the number of background colonies due to some contaminating factor in the DNA, such as intact plasmid template from a PCR. m CRITICAL STEP Never leave the DNA-cell mixes on ice for more than B10 min.
? TROUBLESHOOTING and sequencing where necessary. For confirming insertion of a dsDNA, such as a drug cassette, use two pairs of primers, each pair having one primer outside the targeted flanking region and one primer in the inserted DNA, and amplify the two junctions. Another PCR, using the two outside flanking primers, should also be performed to confirm the absence of the gene to be removed, thus ruling out the possibility of a duplication event 54 .
? TROUBLESHOOTING (B) Outgrowth and selection of recombinant colonies containing genomic fragments retrieved onto a plasmid by subcloning using recombineering: TIMING 2 d (i) Following electroporation, add the 1 ml cell mixture to 9 ml of LB medium and grow the culture overnight nonselectively at 32 1C. (Fig. 6) . Test a total of ten individual colonies corresponding to the 3-5 positive areas on the original plate for each BAC modification. m CRITICAL STEP Only one of the two reactions should be positive if the colony is pure. Occasionally, some colonies will amplify PCR products with both sets of primers, implying that at least one modified and one unmodified copy of the BAC is present. These colonies may be due to BAC multimer formation and should be discarded. (viii) Once correctly targeted pure 'hit' colonies have been identified, repeat the preceding Steps 19D (ii-vii) used for the 'fix' step, beginning with the newly created 'hit' strain. m CRITICAL STEP When using either the mini-l or the pSIM plasmids for recombineering, streak the correct 'hit' clones on the appropriate antibiotic plate to determine whether they have retained the l Red system. If necessary, reintroduce the Red system before proceeding. (ix) Confirm the presence of correct mutation after the 'fix' step by sequencing. (x) Digest both the original and modified BACs with a few commonly used restriction enzymes (e.g., BamHI, EcoRI, EcoRV, HindIII, PstI and so on 
BOX 5 | TESTING COLONY PURITY BY RESTRICTION DIGESTION
For this approach, the region including the modification site is amplified using PCR primers hybridizing outside the region of homology. The purified PCR product should be digested with a restriction enzyme recognizing the 'hit' cassette (Fig. 6) . 
ANTICIPATED RESULTS
Recombineering is an efficient and relatively straightforward method of in vivo genetic engineering that is rapidly becoming routine for modification of the bacterial genome, plasmids, PACs and BACs. As recombineering allows DNA to be precisely inserted, altered or deleted, it is very useful for generation of various genomic constructs for functional studies. Linear DNA, both PCR products and synthetic oligonucleotides (oligos) can be used as substrates to create null mutations in genes as well as more subtle genetic changes. Generally, recombinants are obtained at a frequency of 10 À4 -10 À5 when dsDNA is used to make insertions. For optimized recombineering with ss-oligos or largely homologous denatured PCR fragments, the frequency of recombinants is in the range of 0.1-10%. The frequency of cloning by gene retrieval is lower, in the range of 10 À5 -10 À6 . Insertion of reporter genes at the 5¢-or 3¢-ends of genes cloned in BACs can be easily achieved. There are a number of critical steps in the recombineering procedure; each step should be optimized. Deviations from the protocol may result in suboptimal results; the overall effect of not optimizing each step can be a reduction in recombination efficiency and even failure to generate recombinants. 
